Pharmacotherapy: Cardiovascular effects of aldosterone blockade in CKD.
Division of Cardiology, Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI 48109, USA. bpitt@umich.edu
Bertram
B
Pitt
D001018:Aortic Diseases / Q000150:complications / Q000188:drug therapy*; D002908:Chronic Disease; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced; D017379:Hypertrophy, Left Ventricular / Q000150:complications / Q000188:drug therapy*; D007674:Kidney Diseases / Q000150:complications / Q000188:drug therapy*; D000451:Mineralocorticoid Receptor Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D013148:Spironolactone / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone